Factors linked to the treatment and therapeutic adherence of patients suffering from cardiac insufficiency in an urban health area
Keywords:
heart failure, therapeutic adherence, prescriptionAbstract
Introduction and Objectives: Cardiac insufficiency is a major health problem with a social, economic and human impact. It causes a serious limitation in the quality of life of patients. An important aspect in the patients’ evolution is their adherence to the treatment. In primary health care, not all the professionals are familiar with the therapeutic procedures. This study was aimed at determining the factors linked to the treatment and therapeutic adherence of patients diagnosed with cardiac insufficiency. Methods: a cross-sectional descriptive study of the total amount of patients suffering from cardiac insufficiency (56) in the family doctor’s consulting room Nº 3 of Santa Clara Polyclinic was carried out. The sources of the collected data were the medical certificates, the individual and family medical histories and the personal interviews. Results: cardiac insufficiency prevailed in the age group between 70 and 79 years of age (44,6 %), and among women (66,1 %). The total adherence to the treatment prevailed with 78.6 percent, and the incomplete adherence was 21,4 percent. The most common functional classification were class II (46,4 %) and class III (37,5 %). The digitalics and diuretics were the most common medication (82,1 % and 71,4 % respectively). There was an incorrect treatment in 39.3 percent of the cases and inadequate knowledge in 45 percent of the doctors. Conclusions: The therapeutic adherence of the patients was not linked to age and gender. The incomplete adherence was higher in patients with an inadequate follow up, in functional classifications II and III. The digitalics and diuretics were the most commonly used medications. There was a wrong treatment in a large number of patients, as well as inadequate knowledge in the professionals.
Downloads
References
1. Escasany AA , Durán DM, Arnau de B, Josep M, Rodríguez CD. Tratamiento médico de la insuficiencia cardíaca basado en la evidencia. Rev Esp Cardiol. 2004;54:715-34.
2. Borroto RR. Medicamentos empleados en el tratamiento de la insuficiencia cardíaca. CD Maestría Atención integral a la mujer [CD- ROM]. La Habana: ENSAP; 2006.
3. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, et al. The epidemiology of heart failure. Eur Heart J. 1997;18:08-25.
4. Cairo Sáez G. ABC del diagnóstico y tratamiento de la insuficiencia cardíaca en la atención primaria de salud. IV Encuentro Teórico Universalización y sociedad [CD-ROM]. Santa Clara: Samuel Feijóo; 2008.
5. Koelling TM, Chen RS, Lubwama RN, L'Italien GJ, Eagle KA. The expanding national burden of heart failure in the United States: The influence of heart failure in women. Am Heart J 2004; 147(1): 74-83.
6. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure. JAMA.2005; 293(5): 572-80.
7. Romero Cabrera AJ. Insuficiencia cardíaca en el anciano. un problema no resuelto. Medisur [serie en Internet]. 2004 [citado 5 Mar 2008];2(1):[aprox. 4 p.]. Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/viewArticle/46
8. Gómez Juanola M. Morbilidad geriátrica. Hospital Mario Muñoz. Bienio 1998-1999. Rev Ciencias Méd Pinar del Río [serie en Internet]. 2001 [citado 3 Jun 2009];5(1):[aprox 5 p.]. Disponible en: http://princesa.pri.sld.cu/facultad/revistas/revista1-2001.html#art8
9. Negrín Expósito JE, Fernández-Brito Rodríguez JE, Castillo Herrera JA, Senra Armas G, Gutiérrez Rojas A, Pérez Yn M, et al. Prevalencia y formas de insuficiencia cardíaca en mayores de 65 años. Rev Cubana Invest Bioméd [serie en Internet]. 2007 [citado 3 Jun 2009];26(2):[aprox. 8 p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002007000200002&lng=es&nrm=iso&tlng=es
10. Guía para la práctica clínica: tratamiento de la insuficiencia cardíaca congestiva. Boletín APS [serie en Internet]. 2001 Mar- Abr [citado 14 Jun 2001];13:[aprox. 9 p.]. Disponible en: http://www.cdf.sld.cu/boletin%20insuficiencia%20cardiaca.pdf
11. Furones JA, Céspedes L, Cruz MA, García D, Delgado I, Salazar LE. Guía cubana para la práctica clínica: tratamiento de la insuficiencia cardíaca congestiva. Centro para el Desarrollo de la Farmacoepidemiología. La Habana: MINSAP; 2007. Disponible en: http://www.cdf.sld.cu/gpc/gpciccagree.pdf
12. Cairo Sáez G, Díaz Pérez O. Valoración de la adherencia al tratamiento y su relación con la percepción de riesgo en los ancianos con insuficiencia cardíaca. IV Encuentro Teórico Universalización y Sociedad [CD-ROM]. Santa Clara: Samuel Feijóo; 2008.
13. Cairo Sáez G, Ojeda Blanco JC, Gutiérrez Díaz MJ. Incidencia, prevalencia y manejo de la insuficiencia cardíaca en un grupo básico de trabajo. I Encuentro Teórico Universalización y Sociedad [CD-ROM]. Santa Clara: Samuel Feijóo; 2005.
14. Ward RE, Gheorghiade M, Young JB, Uretsky B. Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol 1995;26: 93-101.
15. Delea TE, Vera-Llonch M, Richner RE, Fowler MB, Oster G. Cost-efectiveness of carvedilol for heart failure. Am J Cardiol 1999; 83:890-6.
16. Martín Alfonso L. Repercusiones para la salud pública de la adherencia terapéutica deficiente. Rev Cubana Salud Pública [serie en Internet]. 2006 [citado 23 Oct 2007]; 32(3):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662006000300013&lng=es&nrm=iso&tlng=es
17. MacIntyre K, Capewell S, Stewart S, Chalmers JWT, Boyd J, Finlayson A, et al. Evidence of improving prognosis in heart failure: Trends in case fatality in 66 547 patients hospitalized between1986 and 1995. Circulation. 2000;102(9):1126-31.
18. Ingaramo R, Vita N, Bendersky M, Arnolt M, Bellido C, Piscorz D. Estudio nacional sobre adherencia al tratamiento (ENSAT). Rev Fed Arg Cardiol [serie en Internet]. 2005 [citado 22 Jun 2006];34(1):[aprox. 8 p.]. Disponible en: http://www.fac.org.ar/1/revista/05v34n1/hta/ingaramo.pdf
19. Anguita Sánchez M y los investigadores del BADIPAC. Características clínicas, tratamiento y morbimortalidad a corto plazo de pacientes con insuficiencia cardíaca controlados en consultas específicas de insuficiencia cardíaca. Resultados del registro BADIPAC. Rev Esp Cardiol. 2004;57(12):1159-69.
20. OMS. La OMS alerta sobre riesgos de incumplimiento del tratamiento médico[serie en Internet].[citado 7 Jun 2003]. Disponible en: http://www.infomed.sld.cu
21. Sansó F. ¿Están nuestros médicos en condiciones de realizar con calidad el acto de la prescripción? Rev Cubana Med Gen Integr [serie en Internet]. 2002 [citado 22 Mar 2002];18(2):[aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662006000300013&lng=es&nrm=iso&tlng=es
22. Pérez Peña J. La prescripción médica es un acto científico, ético y legal. Rev Cubana Med Gen Integr. 2002;18(2):114-6.
23. Basterra Gabarró M. El cumplimiento terapéutico. Pharmaceutical Care. 1999;1:97-106.
24. Pitt B, Poole-Wilson PA, Segal R. Effect of losartan compared with captopril on mortality of patients with symptomatic heart failure. Losartan Heart Failure Survival. Study ELITE II. Lancet. 2000;355: 582-7.
25. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450-6.
26. Eccles M, Freemantle N, Mason J, for the North of England ACE-inhibitor Guideline Development Group. North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symtomatic heart failure. Br Med J 1998; 316: 1369-75.
27. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymtomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992; 327: 685-91.
28. Jovell AJ, Navarro-Rubio MD, Aymerich M, Serra-Prat M. Metodología de diseño y elaboración de guías de práctica clínica en atención primaria. Aten Primaria 1997; 20: 259-66.
29. Hunt S A, Abraham W T, Chin M H, Feldman A M Francis G S, Ganiats T G, et. al.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation; 112:1825-52.
30. Castro P, Pérez O, Greig D, Díaz-Araya G, Moraga F, Chiong M et al. Efectos del carvedilol en la capacidad funcional, función ventricular izquierda, catecolaminas y estrés oxidativo en pacientes con insuficiencia cardíaca crónica. Rev Esp Cardiol 2004; 57 (11) 1053-6.
31. Duaso E, Díaz-Caballero M, Formida F. Abordaje de la insuficiencia cardíaca en ancianos: una visión desde la atención primaria. Rev Esp Cardiol 2006; 59(3): 289-91.
32. Garina O, Sorianob N, Riberab A, Ferrerc M, Pontd A, Alonsoe J, et al. Validación de la versión española del Minnesota Living with Heart Failure Questionnaire. Rev Esp Cardiol 2008; 61: 251-9.
33. Cairo Sáez G, Jiménez Prieto Y, González Rodríguez DS. Predicción de la mortalidad por insuficiencia cardíaca. An Cir Card Cir Vas 2000; 6 (4) 173-9.
34. Lenfand C. Clinical research to clinical practice – Lost in translation? N Engl J Med 2004 348(20):2007-18.
35. Jessup M, Brozena S. Heart Failure. N Engl J Med. 2003;348(20):2007-18.
Downloads
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
